AUS
NZ
UK
CA
USA
IND
_10_04_2024_16_38_50_427275.jpg)
Todd M. DuChene, Chief Legal and Administrative Officer of Core Scientific, Inc. (NASDAQ:CORZZ), sold 10,000 common shares on July 20, 2026, as disclosed in a company insider trading report filed with the Securities and Exchange Commission on July 22, 2026. The shares were sold at a weighted average price of $22.2995 each, executed under a Rule 10b5-1 trading plan established in December 2025. After this transaction, DuChene retains direct beneficial ownership of 1,999,101 shares of Core Scientific common stock.
Key Points
- NASDAQ: CORZZ
- Chief Legal and Administrative Officer Todd M. DuChene sold 10,000 common shares on July 20, 2026
- Transaction completed at a weighted average price of $22.2995 per share; individual trades ranged from $21.99 to $22.71
- Sale conducted under a Rule 10b5-1 trading plan adopted December 5, 2025, enabling predetermined insider trades
- DuChene’s direct beneficial ownership remains at 1,999,101 shares following the sale
Insider Share Sale Executed Within Pre-Established Trading Program
Todd M. DuChene, Core Scientific’s Chief Legal and Administrative Officer, completed the sale of 10,000 common shares on July 20, 2026. The transaction was executed at a weighted average price of $22.2995 per share, with individual sales prices ranging from $21.99 to $22.71. This sale was part of a disciplined execution under a prearranged trading plan rather than an ad hoc market transaction.
The sale was conducted pursuant to a Rule 10b5-1 trading plan adopted on December 5, 2025. Such plans allow insiders to set predetermined schedules for buying or selling securities, providing an affirmative defense under securities laws by demonstrating trades were made without access to material nonpublic information at the plan’s inception.
Core Scientific’s Leadership and Insider Stock Holdings
Core Scientific, Inc. is a blockchain and digital infrastructure company supporting cryptocurrency mining and digital asset services. The company’s leadership includes legal and administrative executives responsible for compliance and governance in this regulated technology sector.
Following the July 20 transaction, DuChene holds 1,999,101 shares of Core Scientific common stock directly. This substantial ownership aligns his financial interests with those of public shareholders and indicates significant exposure to the company’s operational results and stock performance.
Details on Transaction Pricing and Execution
The 10,000 shares were sold through multiple transactions within a price range of $21.99 to $22.71 per share, reflecting a roughly 3.3% spread. The weighted average price of $22.2995 per share represents the overall economic outcome. DuChene has committed to providing detailed pricing information on individual trades to Core Scientific, shareholders, or the SEC upon request, ensuring transparency.
Rule 10b5-1 Plans and Insider Trading Compliance
The transaction exemplifies the use of Rule 10b5-1 plans, which are designed to allow insiders to trade securities according to a predetermined schedule, mitigating concerns about insider trading. DuChene’s plan was adopted more than seven months before the sale, establishing a clear timeline that supports compliance with securities regulations.
Beneficial Ownership Reporting and Calculations
Under Section 16(a) of the Securities Exchange Act, insiders must report changes in beneficial ownership within two business days. DuChene’s reported 1,999,101 shares represent direct beneficial ownership, held personally rather than through intermediaries. Prior to the sale, his ownership was approximately 2,009,101 shares.
Timely Disclosure of Insider Transactions
The sale on July 20, 2026, was reported to the SEC on July 22, 2026, complying with the two-business-day reporting requirement. This prompt disclosure ensures that investors receive timely information about insider trading activity, promoting market transparency.
Core Scientific’s Market Position and Business Overview
Core Scientific operates in the blockchain infrastructure and digital asset services industry, a sector characterized by regulatory changes and market volatility. The company’s revenue depends on cryptocurrency prices, mining difficulty, energy costs, and regulatory conditions. DuChene’s legal and administrative leadership is critical in managing compliance and risk in this dynamic environment.
Insider Ownership as an Indicator for Investors
Executive stock ownership is a key signal of alignment between management and shareholders. DuChene’s sale of 10,000 shares represents about 0.5% of his post-transaction holdings, indicating a routine portfolio adjustment rather than a significant divestment. His substantial remaining ownership suggests confidence in Core Scientific’s future prospects.
Access to Transaction Details for Shareholders
Core Scientific has committed to providing detailed information on the individual prices of the 10,000 shares sold upon request to shareholders or the SEC. The official filing is available on the SEC’s EDGAR database under ticker CORZZ, ensuring public access to comprehensive insider transaction data.
